PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
PVCT was delisted on the 13th of October, 2016.
7 hedge funds and large institutions have $17K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
90% less capital invested
Capital invested by funds: $176K → $17K (-$159K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DT
Diversified Trust
Memphis,
Tennessee
|
+$3K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$1.94K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SB
Sunflower Bank
Dallas,
Texas
|
-$163K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HFBOT
1
Home Federal Bank of Tennessee
Knoxville,
Tennessee
| $6K | – | – | – |
|
|
LDB
2
Lee, Danner & Bass
Nashville,
Tennessee
| $3K | – | – | – |
|
|
3
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $3K | +$1.94K | +37,257 | +183% |
|
|
DT
4
Diversified Trust
Memphis,
Tennessee
| $3K | +$3K | +50,000 | New |
|
|
ACM
5
Academy Capital Management
Waco,
Texas
| $1K | – | – | – |
|
|
AA
6
Ancora Advisors
Cleveland,
Ohio
| $1K | – | – | – |
|
|
SB
7
Sunflower Bank
Dallas,
Texas
| – | -$163K | -2,411,871 | Closed |
|
PVCT Hedge Fund Activity: Q2 2022 in Review
7 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q2 2022, worth a combined $17K — down 90% from $176K a quarter earlier.
Fund positioning in PVCT was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Diversified Trust, opening a new position worth an estimated $3K. The largest seller was Sunflower Bank, exiting entirely with an estimated $163K sold.
- 7 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $17K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q2 2022, down 90% quarter-over-quarter.
- 1 fund opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q2 2022 and 1 closed out, a net change of 0 holders.
- The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) buyer in Q2 2022 was Diversified Trust, an estimated $3K added.
- The largest PROVECTUS BIOPHARMACEUTICALS, INC. (DE) seller in Q2 2022 was Sunflower Bank, an estimated $163K sold.
Based on aggregated 13F filings for Q2 2022.